SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
401 Professional Drive, Suite 260
Gaithersburg, MD 20879
(240) 430-4212
March 6, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Shuttle Pharmaceuticals Holdings, Inc. |
| Registration Statement on Form S-1 | |
| File No. 333-284889 |
Acceleration Request
| Requested Date: | Friday, March 7, 2025 |
| Requested Time: | 4:30 PM Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Shuttle Pharmaceuticals Holdings, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its registration statement on Form S-1 (File No. 333-284889) so that it may become effective at 4:30 p.m. Eastern Time on Friday, March 7, 2025, or at such time as the Registrant may request by telephone to the staff of the Securities and Exchange Commission. In addition, the Registrant hereby authorizes Megan J. Penick, Esq. of Dorsey & Whitney LLP, counsel for the Registrant, to make such request on the Registrant’s behalf.
| Very truly yours, | ||
| Shuttle Pharmaceuticals Holdings, Inc. | ||
| By: | /s/ Anatoly Dritschilo | |
| Name: | Anatoly Dritschilo | |
| Title: | Chief Executive Officer and | |
| Chairman of the Board of Directors | ||